Shinn‐Cherng Chen

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

Ming‐Lung Yu, Chung‐Feng Huang, Jee‐Fu Huang et al. · Hepatology · 2010 · 179 citations · Full text

Medicine, Infectious Diseases, Molecular Genetics +17

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study

Chia‐Yen Dai, Wan‐Long Chuang, Chi‐Kung Ho et al. · Journal of Hepatology · 2008 · 139 citations

Medicine, Health Sciences, Infectious Diseases +15

Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication

Chung‐Feng Huang, Ming‐Lun Yeh, Pei‐Chien Tsai et al. · Journal of Hepatology · 2014 · 133 citations · Full text

Medicine, Infectious Diseases, Oncology +15

Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

Sheng‐Nan Lu, Jing‐Houng Wang, Chien‐Wei Su et al. · Journal of the Formosan Medical Association · 2017 · 119 citations · Full text

Medicine, Oncology, Surgery +13